Greene SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, Lam CSP, Lund LH, Ponikowski P, Voors AA, Zannad F, Zieroth S, Butler J (2023) Worsening heart failure: nomenclature, epidemiology, and future directions: JACC review topic of the week. J Am Coll Cardiol 81(4):413–424. https://doi.org/10.1016/j.jacc.2022.11.023

Article  PubMed  Google Scholar 

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79(17):1757–1780. https://doi.org/10.1016/j.jacc.2021.12.011

Article  PubMed  Google Scholar 

Ledwidge M, Gallagher J, Conlon C, Tallon E, O’Connell E, Dawkins I, Watson C, O’Hanlon R, Bermingham M, Patle A, Badabhagni MR, Murtagh G, Voon V, Tilson L, Barry M, McDonald L, Maurer B, McDonald K (2013) Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial. JAMA 310(1):66–74. https://doi.org/10.1001/jama.2013.7588

Article  CAS  PubMed  Google Scholar 

Berry JD, Nambi V, Ambrosius WT, Chen H, Killeen AA, Taylor A, Toto RD, Soliman EZ, McEvoy JW, Pandey A, Joshi PH, Blankenberg S, Kitzman DW, Ballantyne CM, de Lemos JA (2021) Associations of high-sensitivity troponin and natriuretic peptide levels with outcomes after intensive blood pressure lowering: findings from the SPRINT randomized clinical trial. JAMA Cardiol 6(12):1397–1405. https://doi.org/10.1001/jamacardio.2021.3187

Article  PubMed  PubMed Central  Google Scholar 

Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I, Oral TK, Michelsen MM, Plutzky J, Tornoe CW, Ryan DH, Investigators ST (2023) Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med 389(24):2221–2232. https://doi.org/10.1056/NEJMoa2307563

Article  CAS  PubMed  Google Scholar 

Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Ruff CT, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS, Investigators D-T (2019) Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med 380(4):347–357. https://doi.org/10.1056/NEJMoa1812389

Article  CAS  PubMed  Google Scholar 

Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus M, Devins T, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE, Investigators E-RO (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373(22):2117–2128. https://doi.org/10.1056/NEJMoa1504720

Article  CAS  PubMed  Google Scholar 

Jia X, Al Rifai M, Ndumele CE, Virani SS, de Lemos JA, Lee E, Shah AM, Echouffo-Tcheugui JB, Bozkurt B, Hoogeveen R, Selvin E, Ballantyne CM, Nambi V (2023) Reclassification of pre-heart failure stages using cardiac biomarkers: the ARIC study. JACC Heart Fail 11(4):440–450. https://doi.org/10.1016/j.jchf.2022.12.005

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mohebi R, Wang D, Lau ES, Parekh JK, Allen N, Psaty BM, Benjamin EJ, Levy D, Wang TJ, Shah SJ, Gottdiener JS, Januzzi JL Jr., Ho JE (2023) Effect of 2022 ACC/AHA/HFSA criteria on stages of heart failure in a pooled community cohort. J Am Coll Cardiol 81(23):2231–2242. https://doi.org/10.1016/j.jacc.2023.04.007

Article  PubMed  PubMed Central  Google Scholar 

Abu-Qaoud MR, Kumar A, Tarun T, Abraham S, Ahmad J, Khadke S, Husami R, Kulbak G, Sahoo S, Januzzi JL Jr., Neilan TG, Baron SJ, Martin D, Nohria A, Reynolds MR, Kosiborod M, Dani SS, Ganatra S (2023) Impact of SGLT2 inhibitors on AF recurrence after catheter ablation in patients with type 2 diabetes. JACC Clin Electrophysiol 9(10):2109–2118. https://doi.org/10.1016/j.jacep.2023.06.008

Article  PubMed  Google Scholar 

Avula V, Sharma G, Kosiborod MN, Vaduganathan M, Neilan TG, Lopez T, Dent S, Baldassarre L, Scherrer-Crosbie M, Barac A, Liu J, Deswal A, Khadke S, Yang EH, Ky B, Lenihan D, Nohria A, Dani SS, Ganatra S (2024) SGLT2 Inhibitor use and risk of clinical events in patients with cancer therapy-related cardiac dysfunction. JACC Heart Fail 12(1):67–78. https://doi.org/10.1016/j.jchf.2023.08.026

Article  CAS  PubMed  Google Scholar 

Horiuchi Y, Wettersten N, Asami M, Yahagi K, Komiyama K, Yuzawa H, Tanaka J, Aoki J, Tanabe K (2024) Glucagon-like peptide-1 receptor agonists improve outcomes in individuals with type 2 diabetes with and without heart failure. Int J Cardiol 418:132611. https://doi.org/10.1016/j.ijcard.2024.132611

Article  PubMed  PubMed Central  Google Scholar 

Palchuk MB, London JW, Perez-Rey D, Drebert ZJ, Winer-Jones JP, Thompson CN, Esposito J, Claerhout B (2023) A global federated real-world data and analytics platform for research. JAMIA Open 6(2):ooad035. https://doi.org/10.1093/jamiaopen/ooad035

Article  PubMed  PubMed Central  Google Scholar 

Satti DI, Karius A, Chan JSK, Isakadze N, Yadav R, Garg K, Aronis KN, Marine JE, Berger R, Calkins H, Spragg D (2024) Effects of glucagon-like peptide-1 receptor agonists on atrial fibrillation recurrence after catheter ablation. JACC Clin Electrophysiol 10(8):1848–1855. https://doi.org/10.1016/j.jacep.2024.03.031

Article  PubMed  Google Scholar 

Chamberlain AM, Boyd CM, Manemann SM, Dunlay SM, Gerber Y, Killian JM, Weston SA, Roger VL (2020) Risk factors for heart failure in the community: differences by age and ejection fraction. Am J Med 133(6):e237–e248. https://doi.org/10.1016/j.amjmed.2019.10.030

Article  PubMed  Google Scholar 

Daniels LB, Maisel AS (2007) Natriuretic peptides. J Am Coll Cardiol 50(25):2357–2368. https://doi.org/10.1016/j.jacc.2007.09.021

Article  CAS  PubMed  Google Scholar 

Khatibzadeh S, Farzadfar F, Oliver J, Ezzati M, Moran A (2013) Worldwide risk factors for heart failure: a systematic review and pooled analysis. Int J Cardiol 168(2):1186–1194. https://doi.org/10.1016/j.ijcard.2012.11.065

Article  PubMed  Google Scholar 

Nohara S, Ishii K, Shibata T, Obara H, Miyamoto T, Ueno T, Kakuma T, Fukumoto Y (2023) Risk factor structure of heart failure in patients with cancer after treatment with anticancer agents’ assessment by big data from a Japanese electronic health record. Heart Vessels 38(6):793–802. https://doi.org/10.1007/s00380-023-02238-9

Article  PubMed  PubMed Central  Google Scholar 

Patwardhan AA, Larson MG, Levy D, Benjamin EJ, Leip EP, Keyes MJ, Wang TJ, Gottlieb DJ, Vasan RS (2006) Obstructive sleep apnea and plasma natriuretic peptide levels in a community-based sample. Sleep 29(10):1301–1306. https://doi.org/10.1093/sleep/29.10.1301

Article  PubMed  Google Scholar 

Peterson PN, Rumsfeld JS, Liang L, Albert NM, Hernandez AF, Peterson ED, Fonarow GC, Masoudi FA, American Heart Association Get With the Guidelines-Heart Failure P (2010) A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. Circ Cardiovasc Qual Outcomes 3(1):25–32. https://doi.org/10.1161/CIRCOUTCOMES.109.854877

Article  PubMed  Google Scholar 

Pocock SJ, Ariti CA, McMurray JJ, Maggioni A, Kober L, Squire IB, Swedberg K, Dobson J, Poppe KK, Whalley GA, Doughty RN, Meta-Analysis Global Group in Chronic Heart Failure (2013) Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J 34(19):1404–1413. https://doi.org/10.1093/eurheartj/ehs337

Article  PubMed  Google Scholar 

Taniguchi N, Miyasaka Y, Suwa Y, Harada S, Nakai E, Shiojima I (2023) H(2)ARDD score as a feasible predictor of heart failure events in patients with atrial fibrillation: a validation study. Heart Vessels 38(8):1035–1041. https://doi.org/10.1007/s00380-023-02252-x

Article  PubMed  Google Scholar 

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, Group ESCSD (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726. https://doi.org/10.1093/eurheartj/ehab368

Article  CAS  PubMed  Google Scholar 

Jehn S, Mahabadi AA, Pfohl C, Vogel L, Al-Rashid F, Luedike P, Totzeck M, Rassaf T, Dykun I (2023) BNP and NT-proBNP thresholds for the assessment of prognosis in patients without heart failure. JACC Adv 2(10):100688. https://doi.org/10.1016/j.jacadv.2023.100688

Article  PubMed  PubMed Central  Google Scholar 

Kitai T, Kohsaka S, Kato T, Kato E, Sato K, Teramoto K, Yaku H, Akiyama E, Ando M, Izumi C, Ide T, Iwasaki YK, Ohno Y, Okumura T, Ozasa N, Kaji S, Kashimura T, Kitaoka H, Kinugasa Y, Kinugawa S, Toda K, Nagai T, Nakamura M, Hikoso S, Minamisawa M, Wakasa S, Anchi Y, Oishi S, Okada A, Obokata M, Kagiyama N, Kato NP, Kohno T, Sato T, Shiraishi Y, Tamaki Y, Tamura Y, Nagao K, Nagatomo Y, Nakamura N, Nochioka K, Nomura A, Nomura S, Horiuchi Y, Mizuno A, Murai R, Inomata T, Kuwahara K, Sakata Y, Tsutsui H, Kinugawa K, Japanese Circulation Society, The Japanese Heart Failure Society Joint Working Group (2025) JCS/JHFS 2025 guideline on diagnosis and treatment of heart failure. J Card Fail 31(8):1164–1322. https://doi.org/10.1016/j.cardfail.2025.02.014

Minamisawa M, Anzai T, Inomata T, Kinugawa K, Sakata Y, Sato N, Tsutsui H, Yamamoto K, Yoshimura M, Saito Y, Kuwahara K (2025) 2023 Update of the Japanese Heart Failure Society scientific statement on BNP and NT-proBNP levels in heart failure practice. J Card Fail 31(9):1453–1459. https://doi.org/10.1016/j.cardfail.2025.03.005

Article